Document is current

Any future updates will be listed below

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

Crossref DOI link: https://doi.org/10.1186/s13045-016-0316-8

Published Online: 2016-09-13

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark